Crown Bioscience International

Crown Bioscience International is a global drug discovery and development service company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

History

Crown Bioscience International was founded in 2006 with a mission to address the pressing need for more effective and efficient drug discovery and development in the biopharmaceutical industry. The company has since grown to become a global leader in providing translational platforms and cost-effective drug discovery solutions.

Services

Crown Bioscience offers a wide range of services to support drug discovery and development. These include in vivo pharmacology services, in vitro pharmacology services, bioanalytical services, ADME/PK services, and biomarker discovery services. The company's translational platforms are designed to help clients identify the best clinical candidates and accelerate their path to market.

Research and Development

Crown Bioscience is committed to advancing the field of drug discovery and development through its innovative research and development efforts. The company's R&D team is focused on developing new and improved translational platforms and tools to support the discovery and development of novel therapeutics.

Partnerships

Crown Bioscience has established numerous partnerships with leading biopharmaceutical companies, academic institutions, and research organizations around the world. These partnerships enable the company to leverage its expertise and resources to accelerate the discovery and development of new drugs.

See Also

• Drug discovery
• Drug development
• Biopharmaceutical
• In vivo
• In vitro
• Bioanalytical
• ADME
• PK
• Biomarker